CN Stock MarketDetailed Quotes

Shanghai Pharmaceuticals Holding (601607)

Watchlist
  • 16.56
  • -0.13-0.78%
15min DelayMarket Closed Aug 12 15:00 CST
61.41BMarket Cap10.57P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Pharmaceuticals Holding (601607) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/Q1
2025/FY
2025/Q9
2025/H1
2025/Q1
2024/FY
2024/Q9
2024/H1
2024/Q1
2023/FY
2023/Q9
2023/H1
2023/Q1
2022/FY
2022/Q9
2022/H1
2022/Q1
2021/FY
2021/Q9
2021/H1
Total Operating Revenue
+6.36%75.26B
+3.03%283.58B
+2.60%215.07B
+1.56%141.59B
+0.87%70.76B
+5.75%275.25B
+6.14%209.63B
+5.14%139.41B
+5.93%70.15B
+12.21%260.30B
+13.11%197.51B
+18.70%132.59B
+16.39%66.23B
+7.49%231.98B
+8.47%174.61B
+6.15%111.71B
+10.27%56.90B
+12.46%215.82B
+14.72%160.97B
+20.73%105.24B
Operating Revenue
+6.36%75.26B
+3.03%283.58B
+2.60%215.07B
+1.56%141.59B
+0.87%70.76B
+5.75%275.25B
+6.14%209.63B
+5.14%139.41B
+5.93%70.15B
+12.21%260.30B
+13.11%197.51B
+18.70%132.59B
+16.39%66.23B
+7.49%231.98B
+8.47%174.61B
+6.15%111.71B
+10.27%56.90B
+12.46%215.82B
+14.72%160.97B
+20.73%105.24B
Other Operating Revenues
----
-3.50%1.03B
----
+13.15%481.15M
----
-6.88%1.06B
----
-13.29%425.22M
----
+54.20%1.14B
----
+27.13%490.42M
----
-5.29%741.24M
----
+11.69%385.75M
----
+61.06%782.66M
----
+47.21%345.37M
Total Operating Cost
+6.06%72.83B
+3.22%276.28B
+2.94%209.41B
+2.02%137.61B
+1.14%68.67B
+5.80%267.68B
+6.30%203.43B
+5.21%134.89B
+6.03%67.89B
+12.49%253.01B
+13.27%191.38B
+19.12%128.21B
+16.29%64.03B
+7.28%224.91B
+8.42%168.95B
+5.87%107.63B
+10.25%55.06B
+12.98%209.64B
+15.08%155.83B
+21.01%101.66B
Cost of Sales
+5.77%67.17B
+3.49%253.16B
+3.33%192.65B
+2.77%126.66B
+2.22%63.51B
+6.84%244.62B
+7.44%186.45B
+6.67%123.25B
+7.87%62.12B
+13.63%228.97B
+14.22%173.55B
+19.50%115.53B
+16.19%57.59B
+7.59%201.49B
+9.10%151.93B
+5.98%96.68B
+11.02%49.57B
+13.38%187.28B
+15.90%139.26B
+23.19%91.23B
Operating Tax Surcharges
+18.91%241.44M
+9.81%854.16M
+6.89%635.97M
+4.00%415.65M
-2.64%203.04M
+5.39%777.88M
+8.50%594.97M
+5.97%399.68M
+8.20%208.54M
+3.05%738.11M
+1.71%548.36M
+0.73%377.17M
+5.29%192.74M
+7.51%716.27M
+11.87%539.14M
+15.34%374.45M
+12.39%183.05M
+12.35%666.23M
+15.50%481.92M
+24.29%324.65M
Operating Expense
+18.61%3.27B
+3.87%13.21B
-1.70%9.32B
-6.09%6.16B
-16.11%2.76B
-8.55%12.71B
-9.46%9.48B
-15.10%6.57B
-15.86%3.29B
-2.64%13.90B
+1.29%10.47B
+13.81%7.73B
+18.05%3.91B
+7.22%14.28B
+1.18%10.34B
+7.42%6.79B
+4.23%3.31B
+9.53%13.32B
+9.56%10.22B
+3.34%6.32B
Administrative Expenses
-0.65%1.32B
-6.63%5.31B
+0.65%4.17B
-7.21%2.66B
-4.81%1.32B
-0.38%5.69B
-1.22%4.14B
+3.86%2.87B
+0.90%1.39B
+14.43%5.71B
+11.62%4.19B
+19.00%2.76B
+15.70%1.38B
-2.95%4.99B
+5.09%3.76B
-0.03%2.32B
-2.57%1.19B
+8.70%5.14B
+2.13%3.57B
+4.38%2.32B
Research and Development
-5.79%468.22M
-2.27%2.34B
-6.23%1.52B
-13.22%958.95M
-0.88%497.02M
+8.64%2.39B
+10.09%1.62B
+7.67%1.11B
-7.26%501.45M
+4.35%2.20B
+5.70%1.47B
+26.76%1.03B
+20.82%540.69M
+6.29%2.11B
+1.63%1.39B
-7.99%809.67M
+7.95%447.50M
+19.96%1.99B
+31.38%1.37B
+30.04%880.03M
Financial Expense
-4.78%356.82M
-4.98%1.41B
-2.99%1.11B
+6.21%749.77M
+0.08%374.72M
-0.33%1.48B
-0.45%1.15B
-8.70%705.94M
-10.46%374.43M
+13.14%1.49B
+15.71%1.15B
+19.16%773.22M
+16.64%418.18M
+5.45%1.31B
+7.26%997.59M
+12.10%648.91M
+13.43%358.53M
+0.47%1.25B
-5.04%930.05M
-13.67%578.87M
-Interest Financial Expense
-21.72%347.64M
-9.20%1.69B
-7.65%1.28B
-3.28%887.69M
-5.85%444.08M
-1.50%1.86B
-5.10%1.39B
-4.64%917.77M
-4.13%471.67M
+11.59%1.88B
+18.90%1.46B
+14.94%962.46M
+20.64%491.99M
+11.27%1.69B
+10.26%1.23B
+17.76%837.34M
+12.46%407.82M
+7.53%1.52B
-1.45%1.11B
-6.88%711.08M
-Interest Financial Income
+53.65%-38.70M
+22.48%-404.97M
+25.62%-270.23M
+31.31%-176.38M
+38.73%-83.49M
-13.11%-522.39M
-1.84%-363.30M
-20.80%-256.78M
-25.24%-136.28M
-5.37%-461.83M
-5.04%-356.74M
+1.95%-212.57M
-36.35%-108.81M
-29.60%-438.30M
-43.39%-339.63M
-37.13%-216.80M
+6.47%-79.81M
-17.29%-338.18M
-2.80%-236.85M
-11.98%-158.10M
Credit Impairment Loss
-7.47%-274.44M
-154.11%-574.71M
-44.56%-624.80M
-44.57%-423.97M
+5.07%-255.37M
+19.22%-226.16M
-45.77%-432.22M
+12.80%-293.26M
-300.73%-269.02M
+10.40%-279.96M
-17.46%-296.51M
-54.49%-336.32M
+4.75%-67.13M
-46192.99%-312.46M
+12.74%-252.44M
-8.25%-217.69M
+23.34%-70.48M
-98.29%677.89K
-4.48%-289.30M
-31.03%-201.10M
Asset Impairment Loss
-314.84%-72.02M
-65.79%-1.02B
-1119.12%-789.41M
-1022.70%-410.08M
+23.13%33.52M
-9.46%-614.37M
-290.94%-64.75M
-155.26%-36.53M
+126.50%27.22M
-69.33%-561.28M
+30.98%33.91M
+67.55%66.10M
-404.59%-102.74M
-136.02%-331.47M
-9.18%25.89M
+152.32%39.45M
+1789.06%33.73M
+84.37%-140.44M
+109.33%28.51M
+106.74%15.63M
Fair Value Change Income
+62.44%61.41M
+62.92%332.12M
-20.44%113.14M
-33.72%75.75M
-27.65%37.80M
-49.63%203.85M
-40.51%142.20M
-41.94%114.29M
-41.55%52.25M
+85.03%404.73M
+225.04%239.02M
+675.23%196.84M
+240.65%89.40M
+206.18%218.74M
+141.65%73.54M
+171.34%25.39M
+47.56%-63.56M
-276.38%-206.00M
-259.61%-176.57M
-134.42%-35.59M
Investment income
-108.22%-14.12M
+733.31%3.17B
+881.11%3.37B
+1222.17%3.26B
+3.18%171.74M
+658.44%380.43M
+509.78%343.49M
+223.81%246.36M
+7.27%166.44M
-112.78%-68.12M
-118.83%-83.82M
-164.35%-198.99M
-13.67%155.16M
-70.57%533.12M
-75.51%445.24M
-81.50%309.25M
-87.92%179.73M
+85.56%1.81B
+142.31%1.82B
+215.73%1.67B
-Investment Income Associates
-87.49%27.00M
-45.49%284.47M
+7.10%479.62M
+4.12%380.66M
+6.17%215.83M
+303.55%521.91M
+398.03%447.83M
+658.88%365.61M
+0.79%203.28M
-75.45%129.33M
-83.05%89.92M
-117.33%-65.42M
+1.23%201.68M
-33.29%526.74M
-31.04%530.52M
-38.10%377.55M
-38.11%199.24M
-21.79%789.60M
-1.94%769.31M
+10.44%609.99M
Asset Deal Income
+18791.20%168.79M
-16.39%157.15M
+9.78%160.09M
-71.30%39.99M
-100.82%-903.05K
+103.26%187.97M
+39.44%145.83M
+88.91%139.31M
+405.21%110.04M
-93.57%92.48M
-92.67%104.58M
-94.83%73.75M
+188.72%21.78M
+2368.58%1.44B
+22234.19%1.43B
+23988.34%1.43B
+7912.76%7.54M
+11.77%58.29M
+463.86%6.39M
+587.44%5.92M
Other Revenues
+71.50%109.28M
-8.60%579.81M
+30.28%441.45M
+127.74%313.70M
-4.65%63.72M
-20.02%634.37M
-21.25%338.85M
-62.81%137.74M
-66.80%66.83M
+101.43%793.16M
+76.49%430.28M
+172.59%370.36M
+178.59%201.32M
-21.06%393.76M
-10.20%243.79M
-29.46%135.87M
+19.20%72.27M
-9.13%498.79M
-7.80%271.47M
-16.61%192.60M
Operating Profit
+12.49%2.41B
+22.13%9.94B
+25.01%8.34B
+41.46%6.83B
-11.11%2.15B
+6.18%8.14B
+1.72%6.67B
+5.99%4.83B
-3.05%2.41B
-14.95%7.67B
-13.98%6.56B
-21.40%4.56B
+24.83%2.49B
+9.86%9.01B
+12.06%7.62B
+10.88%5.80B
-33.31%2.00B
+14.21%8.21B
+24.17%6.80B
+43.94%5.23B
Add:Non-operating Income
+18.29%22.17M
-32.45%105.65M
+115.09%73.32M
+44.98%21.84M
+29.26%18.74M
+284.37%156.40M
+23.92%34.09M
-16.81%15.06M
+3.94%14.50M
+24.14%40.69M
+40.32%27.51M
+81.03%18.11M
+202.29%13.95M
-60.01%32.78M
-75.24%19.60M
-63.89%10.00M
-78.66%4.61M
-57.47%81.96M
-13.99%79.19M
+0.64%27.70M
Less:Non-operating Expense
+40.50%17.44M
-17.75%227.93M
+91.52%111.99M
+44.69%34.64M
-0.53%12.41M
-57.60%277.11M
-9.29%58.48M
-43.54%23.94M
-1.31%12.48M
+173.40%653.63M
-11.74%64.47M
-17.26%42.40M
-3.91%12.65M
+66.45%239.08M
-12.95%73.04M
+27.28%51.24M
-19.47%13.16M
-28.77%143.63M
-11.11%83.91M
-29.56%40.26M
Gross Profit
+12.38%2.42B
+22.44%9.82B
+24.89%8.30B
+41.45%6.82B
-10.92%2.15B
+13.69%8.02B
+1.92%6.64B
+6.36%4.82B
-3.02%2.42B
-19.91%7.05B
-13.86%6.52B
-21.26%4.53B
+25.44%2.49B
+8.16%8.81B
+11.35%7.57B
+10.36%5.76B
-33.72%1.99B
+13.50%8.14B
+24.13%6.80B
+44.78%5.22B
Less:Income tax
+11.04%569.09M
+32.38%2.85B
+42.62%2.31B
+49.11%1.83B
-7.00%512.52M
+13.89%2.15B
+3.57%1.62B
+9.66%1.22B
+2.28%551.13M
+3.93%1.89B
-1.16%1.57B
-6.45%1.12B
+18.63%538.85M
-2.83%1.82B
+10.54%1.58B
+13.39%1.19B
-26.63%454.25M
+19.04%1.87B
+28.20%1.43B
+45.67%1.05B
Net Profit
+12.80%1.85B
+18.80%6.97B
+19.17%5.99B
+38.85%4.99B
-12.08%1.64B
+13.62%5.87B
+1.40%5.02B
+5.28%3.60B
-4.48%1.87B
-26.11%5.17B
-17.22%4.95B
-25.14%3.42B
+27.46%1.95B
+11.43%6.99B
+11.56%5.98B
+9.59%4.56B
-35.56%1.53B
+11.94%6.27B
+23.09%5.36B
+44.55%4.16B
Net Profit from Continuing Operations
+12.80%1.85B
+18.80%6.97B
+19.17%5.99B
+38.85%4.99B
-12.08%1.64B
+13.62%5.87B
+1.40%5.02B
+5.28%3.60B
-4.48%1.87B
-26.11%5.17B
-17.22%4.95B
-25.14%3.42B
+27.46%1.95B
+11.43%6.99B
+11.56%5.98B
+9.59%4.56B
-35.56%1.53B
+11.94%6.27B
+23.09%5.36B
+44.55%4.16B
Less:Minority Profit
+40.77%432.35M
-5.19%1.25B
-13.42%839.08M
-18.24%535.92M
-5.00%307.12M
-5.80%1.32B
-16.24%969.12M
-18.80%655.45M
-25.75%323.29M
+1.72%1.40B
-1.14%1.16B
-7.07%807.18M
+54.77%435.40M
+16.41%1.37B
+33.04%1.17B
+45.49%868.61M
+9.10%281.31M
+6.50%1.18B
+16.39%879.72M
+36.21%597.03M
Net Profit of Parent Company Owners
+6.35%1.42B
+25.74%5.72B
+26.96%5.15B
+51.56%4.46B
-13.56%1.33B
+20.82%4.55B
+6.78%4.05B
+12.72%2.94B
+1.62%1.54B
-32.92%3.77B
-21.13%3.80B
-29.38%2.61B
+21.31%1.52B
+10.28%5.62B
+7.35%4.81B
+3.58%3.70B
-40.99%1.25B
+13.28%5.09B
+24.49%4.48B
+46.05%3.57B
Basic EPS
+5.56%0.38
+25.20%1.54
+27.52%1.39
+51.90%1.20
-14.29%0.36
+20.59%1.23
+5.83%1.09
+11.27%0.79
+2.44%0.42
-36.65%1.02
-28.97%1.03
-37.17%0.71
-6.82%0.41
-10.06%1.61
-8.23%1.45
-10.32%1.13
-41.33%0.44
+13.29%1.79
+24.41%1.58
+46.51%1.26
Diluted EPS
+5.56%0.38
+25.20%1.54
+27.52%1.39
+51.90%1.20
-14.29%0.36
+20.59%1.23
+5.83%1.09
+11.27%0.79
+2.44%0.42
-36.65%1.02
-28.97%1.03
-37.17%0.71
-6.82%0.41
-10.06%1.61
-8.23%1.45
-10.32%1.13
-41.33%0.44
+13.29%1.79
+24.41%1.58
+46.51%1.26
Other Composite Income
-387.46%-16.78M
+112.14%7.60M
+153.30%14.17M
+155.21%19.68M
-842.99%-3.44M
+50.59%-62.62M
+84.45%-26.59M
+70.99%-35.64M
+101.48%463.24K
+44.05%-126.72M
+53.77%-170.97M
+26.23%-122.85M
+17.92%-31.35M
-359.02%-226.48M
-752.29%-369.83M
-652.70%-166.53M
+35.51%-38.20M
-68.87%87.44M
-24.25%56.70M
+133.35%30.13M
Other Composite Income of Parent Company Owners
-205.16%-18.86M
+103.43%1.31M
+91.30%-3.03M
+112.84%4.16M
-25.78%-6.18M
+69.39%-38.19M
+79.19%-34.85M
+74.46%-32.41M
+83.92%-4.91M
+45.02%-124.77M
+54.18%-167.44M
+21.83%-126.92M
+24.57%-30.56M
-287.52%-226.93M
-629.57%-365.39M
-419.87%-162.37M
+25.07%-40.51M
-57.66%121.02M
-17.98%69.00M
+163.66%50.76M
Other Composite Income of Minority Owners
-24.03%2.08M
+125.76%6.29M
+108.20%17.20M
+580.25%15.52M
-49.08%2.74M
-1150.05%-24.43M
+334.02%8.26M
-179.44%-3.23M
+774.36%5.38M
-535.08%-1.95M
+20.56%-3.53M
+197.68%4.07M
-134.54%-797.26K
+101.34%449.15K
+63.86%-4.44M
+79.81%-4.16M
+144.60%2.31M
-573.25%-33.58M
-32.55%-12.30M
-94.32%-20.63M
Total Composite Income
+12.01%1.83B
+20.21%6.98B
+20.09%6.00B
+40.79%5.01B
-12.29%1.64B
+15.23%5.81B
+4.47%5.00B
+8.12%3.56B
-2.90%1.87B
-25.51%5.04B
-14.81%4.78B
-25.09%3.29B
+28.62%1.92B
+6.34%6.77B
+3.57%5.61B
+4.83%4.40B
-35.56%1.49B
+8.08%6.36B
+22.29%5.42B
+50.31%4.19B
Total Composite Income of Parent Company Owners
+5.43%1.40B
+26.84%5.73B
+27.98%5.14B
+53.40%4.46B
-13.69%1.33B
+23.91%4.51B
+10.75%4.02B
+17.18%2.91B
+3.38%1.54B
-32.41%3.64B
-18.41%3.63B
-29.73%2.48B
+22.85%1.49B
+3.37%5.39B
-2.30%4.45B
-2.36%3.53B
-41.41%1.21B
+9.04%5.21B
+23.52%4.55B
+53.13%3.62B
Total Composite Income of Minority Owners
+40.20%434.43M
-2.91%1.26B
-12.39%856.29M
-15.45%551.44M
-5.72%309.86M
-7.42%1.29B
-15.27%977.38M
-19.60%652.22M
-24.37%328.67M
+1.55%1.40B
-1.07%1.15B
-6.15%811.25M
+53.23%434.60M
+19.85%1.38B
+34.41%1.17B
+49.97%864.45M
+12.25%283.62M
+3.94%1.15B
+16.19%867.42M
+34.77%576.40M
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
2026/Q12025/FY2025/Q92025/H12025/Q12024/FY2024/Q92024/H12024/Q12023/FY2023/Q92023/H12023/Q12022/FY2022/Q92022/H12022/Q12021/FY2021/Q92021/H1

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

- No more -